A review of data systems for assessing the impact of HPV vaccination in selected high-income countries.

IF 5.5 3区医学 Q1 IMMUNOLOGY Expert Review of Vaccines Pub Date : 2023-01-01 DOI:10.1080/14760584.2023.2162505

Wei Vivian Wang, Smita Kothari, Hanane Khoury, Linda Niccolai, Suzanne M Garland, Karin Sundström, Gérard de Pouvourville, Paolo Bonanni, Ya-Ting Chen, Eduardo L Franco

{"title":"A review of data systems for assessing the impact of HPV vaccination in selected high-income countries.","authors":"Wei Vivian Wang, Smita Kothari, Hanane Khoury, Linda Niccolai, Suzanne M Garland, Karin Sundström, Gérard de Pouvourville, Paolo Bonanni, Ya-Ting Chen, Eduardo L Franco","doi":"10.1080/14760584.2023.2162505","DOIUrl":null,"url":null,"abstract":"Introduction: The introduction of effective human papillomavirus (HPV) vaccination, screening, and treatment programs has led the World Health Organization to call for the global elimination of cervical cancer. Assessing progress toward this goal is supported through monitoring vaccination coverage and its impact.Areas covered: We performed a targeted review to assess the characteristics of HPV-related data systems from seven high-income countries (HICs) that represented varied approaches, including Australia, Canada, France, Italy, Scotland, Sweden, and the United States (US). Included data systems focused on preventive and early detection measures: HPV vaccination and cervical screening programs, as well as HPV-related disease outcomes. Differences were observed in approach to development of data systems, along with variation in geographical scope and methods of data collection.Expert opinion: A challenge exists in how to best follow-up the ongoing global-scale elimination efforts in a comprehensive manner. These sources provide a wealth of information regarding the strengths and limitations of, and notable variation among, current data systems used in HICs. This review can inform improvements to existing prevention programs and the implementation of new programs in other countries, and thus support optimization of cervical cancer prevention policy.","PeriodicalId":12326,"journal":{"name":"Expert Review of Vaccines","volume":null,"pages":null},"PeriodicalIF":5.5000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Vaccines","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14760584.2023.2162505","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 1

Abstract

Introduction: The introduction of effective human papillomavirus (HPV) vaccination, screening, and treatment programs has led the World Health Organization to call for the global elimination of cervical cancer. Assessing progress toward this goal is supported through monitoring vaccination coverage and its impact.

Areas covered: We performed a targeted review to assess the characteristics of HPV-related data systems from seven high-income countries (HICs) that represented varied approaches, including Australia, Canada, France, Italy, Scotland, Sweden, and the United States (US). Included data systems focused on preventive and early detection measures: HPV vaccination and cervical screening programs, as well as HPV-related disease outcomes. Differences were observed in approach to development of data systems, along with variation in geographical scope and methods of data collection.

Expert opinion: A challenge exists in how to best follow-up the ongoing global-scale elimination efforts in a comprehensive manner. These sources provide a wealth of information regarding the strengths and limitations of, and notable variation among, current data systems used in HICs. This review can inform improvements to existing prevention programs and the implementation of new programs in other countries, and thus support optimization of cervical cancer prevention policy.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

在选定的高收入国家评估HPV疫苗接种影响的数据系统综述。

导言:有效的人乳头瘤病毒(HPV)疫苗接种、筛查和治疗方案的引入，促使世界卫生组织呼吁全球消除宫颈癌。通过监测疫苗接种覆盖率及其影响，支持评估实现这一目标的进展。涵盖领域:我们进行了一项有针对性的综述，以评估来自七个高收入国家(HICs)的hpv相关数据系统的特征，这些国家代表了不同的方法，包括澳大利亚、加拿大、法国、意大利、苏格兰、瑞典和美国。包括侧重于预防和早期检测措施的数据系统:HPV疫苗接种和子宫颈筛查计划，以及HPV相关疾病的结果。数据系统的发展方法存在差异，地理范围和数据收集方法也存在差异。专家意见:在如何以全面的方式最好地跟进正在进行的全球范围消除努力方面存在着挑战。这些来源提供了大量关于高收入国家目前使用的数据系统的优势和局限性以及不同数据系统之间的显著差异的信息。这一综述可以为其他国家现有预防规划的改进和新规划的实施提供信息，从而支持宫颈癌预防政策的优化。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Expert Review of Vaccines 医学-免疫学

CiteScore

9.10

自引率

3.20%

发文量

136

审稿时长

4-8 weeks

期刊介绍： Expert Review of Vaccines (ISSN 1476-0584) provides expert commentary on the development, application, and clinical effectiveness of new vaccines. Coverage includes vaccine technology, vaccine adjuvants, prophylactic vaccines, therapeutic vaccines, AIDS vaccines and vaccines for defence against bioterrorism. All articles are subject to rigorous peer-review. The vaccine field has been transformed by recent technological advances, but there remain many challenges in the delivery of cost-effective, safe vaccines. Expert Review of Vaccines facilitates decision making to drive forward this exciting field.